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Red ﬂuorescent protein (RFP) DsRed and its variants are widely applied in live-cell imaging exper-
iments. However, a major factor that restricts the application of DsRed is its cytotoxicity. Here, we
report that DsRed and its variant DsRed-Express2 inhibit the expression of B-cell lymphoma-extra
large (Bcl-xL) in HeLa cells by translational regulation. Over-expression of Bcl-xL can reduce the
cytotoxicity of DsRed. Meanwhile, Turbo RFP, a mutant RFP from Entacmaea quadricolor, does not
affect Bcl-xL expression, suggesting that cytotoxic mechanisms of RFP from different species may
be varied. Our results reveal a possible mechanism for the cytotoxicity of DsRed, providing a poten-
tial strategy to improve the application of DsRed and its variants.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction may take days at room temperature. Secondly, DsRed is prone toDsRed is a red ﬂuorescent protein (RFP) from coral Discosoma
sp. [1], with the excitation and emission maxima at 558 and
583 nm, respectively [2]. DsRed is homologous to green ﬂuorescent
protein (GFP), which forms an 11-strand b barrel and a chromo-
phore embedded inside the barrel [3]. It has a much higher extinc-
tion coefﬁcient and ﬂuorescent quantum yield compared to GFP,
and it quite resists to photo bleaching with a wider pH tolerance
range (4.5–12). These advantages attracted tremendous interests
for applications in live-cell imaging [2,4].
Despite the great potential in application, DsRed has several
drawbacks. First, the maturation of DsRed is extremely slow, whichchemical Societies. Published by E
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ell lymphoma 2; Bcl-xL, B-cell
logical Science and Medical
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niversity, Beijing, China. Fax:
eng), binxia@pku.edu.cn (B.oligomerization and aggregation [5]. Finally, the cytotoxicity of
wild type DsRed and its variants severely limits its application.
Although several improved variants such as DsRed-Monomer [5],
DsRed.T4 [6], and DsRed2 [7] have been developed by site-direct
mutagenesis, cells expressing high levels of DsRed or its variants
still show growth defects and/or instability [8–10]. This problem
is much more prominent in DsRed compared to GFP and other
green ﬂuorescent variants. Although it was speculated that the
cytotoxicity was caused by the aggregation of DsRed proteins
[10], the molecular mechanism of the DsRed-mediated cytotoxicity
remains to be elucidated [11].
B-cell lymphoma-extra large (Bcl-xL) and B-cell lymphoma 2
(Bcl-2) are members of Bcl-2 protein family [12]. They are highly
similar both in protein sequence and structure. Both of them are
antiapoptotic proteins, which help cells to be more resistant to
apoptosis [13,14]. The expression of Bcl-xL andBcl-2 is up-regulated
in many types of cancer cells [15]. Inhibitors of Bcl-xL and Bcl-2 can
induce apoptosis or autophagic cell death in cancer cells [16,17]. Be-
sides, Bcl-xL and Bcl-2 are normally localized to mitochondrial
membranes because the C-terminal of proteins contains a mito-
chondrial signal, targeting them to the mitochondria [15].
Here we report that DsRed and its variant DsRed-Express2
inhibit the expression of Bcl-xL protein in HeLa cells. Meanwhile,lsevier B.V. All rights reserved.
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results may provide a potential strategy to alleviate cytotoxic prob-
lem of DsRed and its variants.
2. Materials and methods
2.1. Plasmids construction
Vectors of Wassabi GFP and pDsRedN1 were purchased from Al-
lele Biotech (USA) and Clontech (USA), respectively. Turbo RFP plas-
mid was obtained from Origene (USA). DsRed-Express2 was
provided by Dr. Benjamin S. Glick. Synthetic oligonucleotide prim-
ers were listed in Supplementary Table 1. Bcl-xL and Bcl-2 cDNA
were kept in our lab. Bcl-xL fragment with restrictions enzyme sites
XhoI and EcoRIwas generated by PCRwith primers ZJ01n and ZJ02c.
Bcl-2 fragment with restrictions enzyme sites XhoI and EcoRI was
generated by PCR with primers ZJ03n and ZJ04c. Both Bcl-xL and
Bcl-2 fragments were ligated into the vector of WasabiC GFP.
GFP-(⁄)-Bcl-xL plasmid (⁄ indicated a stop code) was generated
from GFP-Bcl-xL plasmid by site-directed mutagenesis kit (Beijing
SBS Genetech, China) with the primers ZJ05n and ZJ06c.
2.2. Cell culture and transfection
HeLa cells were maintained in a humidiﬁed incubator at 37 C
with 5% CO2 and grown in Dulbecco’s modiﬁed eagle medium con-
taining 10% fetal calf serum (Hyclone, USA). Cells were plated into
24-well tissue culture plates. After the density of cells reached 70%,
cells were transiently transfected with plasmids as described using
Lipofectamine 2000 (Invitrogen, USA).
2.3. Fluorescent image
Fluorescent cells were observed using a Leica Digital Micro-
scope Inverted 6000B inverted ﬂuorescence microscope. The
images were captured by a Leica digital ﬁrewire camera 420
charge-coupled device under a 40 objective and recorded on a
PC using Leica Application Suite (v2.5.0 R1).
2.4. Western blotting
Cells were transfected with plasmids as indicated in the Section
3. After 36 h, cells were harvested and lysed by cell lysis solution
(Beyotime, China) for Western blotting analysis. The antibodies
for assays were anti-Bcl-xL mAb (Invitrogen, USA) diluted 1:200,
anti-His mAb (Santa Crutz, USA) diluted 1:1000, anti-b-actin
mAb (Santa Crutz, USA) diluted 1:1000, and goat-anti-mouse IgG
(Santa Crutz, USA) diluted 1:4000.
2.5. Transcription regulation assay of Bcl-xL in HeLa cells and RT-PCR
Total RNA in cells co-transfected with plasmids encoding
GFP-Bcl-xL and DsRed or empty vector, was extracted by TRNzol
(TianGen, China). RT-PCR was used to amplify a fragment of cDNA.
The primers which used for ampliﬁcations of indicated fragments
were listed in Supplementary Table 2. ZJ07n and ZJ08cwere for gen-
erating exogenous Bcl-xL fragments which is 492 bp from nt 482 of
GFP to nt 296 of Bcl-xL. ZJ09n and ZJ10c were for generating endog-
enous Bcl-xL fragmentswhich is 202 bp fromnt 400 to nt 602. ZJ11n
and ZJ12c were for generating GAPDH fragments which is 372 bp.
2.6. Apoptosis assay
Apoptosis was detected by Hoechst 33342 staining kit
(Beyotime, China). The condensed chromatin of apoptotic cellswere stained brightly by Hoechst 33342, while the normal chroma-
tin of live cells were stained more weakly, which makes it possible
to distinguish normal and apoptotic cells under ﬂuorescence
microscopy.
2.7. Fluorescence intensity assay
HeLa cells were transiently co-transfected by various construct
plasmids accordingly. 20 000 cells were sorted by ﬂow cytometry
(FacsAir ﬂow cytometer, BD Biosciences) under identical condition
(488 nm laser for GFP and 543 nm laser for RFPs). Data were pro-
cessed using Flow cytometry software Summit V4.0.
To measure the growth of cells expressing ﬂuorescent proteins,
DsRed, DsRed-Express2 and Turbo RFP plasmids were co-
transfected with pcDNA4.0 and pcDNA4.0-Bcl-xL plasmids
respectively. Cells of four wells in a 24-wells plate were harvested
at speciﬁc time from 12 to 84 h after transiently transfection.
Viable ﬂuorescence cells were counted and analyzed from 20 000
cells sorted by ﬂow cytometry. Data were processed using Flow
cytometry software Summit V4.0.
3. Results and discussion
3.1. DsRed and its variant DsRed-Express2 down-regulates Bcl-xL
protein in HeLa cells
When we co-transfected plasmids encoding DsRed and GFP-
Bcl-xL into HeLa cells, we accidentally observed that green ﬂuores-
cence intensity of cells expressing both DsRed and GFP-Bcl-xL
(Fig. 1b2) was much weaker than that of cells expressing GFP-Bcl-
xL only (Fig. 1a2). However, therewasno obvious difference in green
ﬂuorescence intensity between cells expressing bothDsRed andGFP
(Fig. 1b1) and cells expressingGFPonly (Fig. 1a1). Thus, it seems that
the green ﬂuorescence could be suppressed by DsRed when GFP is
fused to Bcl-xL. As Bcl-2 is a homologous protein of Bcl-xL, we
also tried to co-transfect plasmids encoding DsRed and GFP-Bcl-2
into HeLa cells. No obvious difference in green ﬂuorescence
intensity was observed between cells expressing both DsRed and
GFP-Bcl-2 (Fig. 1b3) and cells expressing GFP-Bcl-2 only
(Fig. 1a3). Thus, it seems that the effect of DsRed is speciﬁc for
Bcl-xL.
Since DsRed-Express2 was reported to be an improved variant
of DsRed [10], we co-transfected plasmids encoding GFP-Bcl-xL
and DsRed-Express2. The green ﬂuorescence intensity of cells
expressing both DsRed-Express2 and GFP-Bcl-xL (Fig. 1f2) was also
much weaker than that of cells expressing GFP-Bcl-xL only
(Fig. 1a2). And there was no decline of green ﬂuorescence intensity
in cells expressing DsRed-Express2 and GFP (Fig. 1f1) or in cells
expressing GFP-Bcl-2 and DsRed-Express2 (Fig. 1f3).
To further ascertain the green ﬂuorescence intensity of GFP-
Bcl-xL was decreased by DsRed and its variant DsRed-Express2,
we examined green ﬂuorescence of cells by ﬂow cytometry. The
average green ﬂuorescence intensity was obviously decreased by
overexpression of DsRed and DsRed-Express2 (Fig. 2A). The nor-
malized green ﬂuorescence intensity was decreased to 22.45 and
30.46, respectively (Fig. 2B).
We then carried out western blotting to analyze the protein
expression level of GFP-Bcl-xL. The results showed that the amount
of GFP-Bcl-xL protein is signiﬁcantly lower in cells expressing GFP-
Bcl-xL and DsRed than that in cells expressing GFP-Bcl-xL only
(Fig. 3). Similar results were also obtained in cells expressing
GFP-Bcl-xL and DsRed-Express2 (Fig. 3). Further, we found that
the endogenous Bcl-xL protein levels were also lowered in HeLa
cells co-transfected with plasmids encoding DsRed or DsRed-
Express2 with GFP-Bcl-xL (Fig. 3). Therefore, the over-expression
Fig. 1. Fluorescent image results showing that inhibition of green ﬂuorescence of GFP-Bcl-xL or GFP(⁄)-Bcl-xL by DsRed or DsRed-Express2 in HeLa cells. (a1–g4)
Representative ﬂuorescence images of HeLa cells co-transfected with plasmids expressing different combination of proteins as indicated in the panel. Over-expression of
DsRed or DsRed-Express2 can decrease the green ﬂuorescence intensity of GFP-Bcl-xL (b2 and f2). Meanwhile, over-expression of DsRed or DsRed-Express2 does not decrease
green ﬂuorescence intensity of GFP (b1 and f1) or GFP-Bcl-2 (b3 and f3). Over-expression of Turbo RFP does not decrease green ﬂuorescence intensity of GFP (d1), GFP-Bcl-xL
(d2), and GFP-Bcl-2 (d3). The green ﬂuorescence intensity in cells expressing both DsRed/DsRed-Express2 and GFP(⁄)-Bcl-xL (⁄ stop codon) was also weaker (b4 and f4) than
that in cells expressing GFP(⁄)-Bcl-xL alone (a4). However, there was no obvious difference in green ﬂuorescence intensity between cells expressing Turbo RFP and GFP (d1)
and cells expressing Turbo RFP and GFP(⁄)-Bcl-xL (d4). Exposure time for green ﬂuorescent images was 800 ms. Exposure time for red ﬂuorescent images of Turbo RFP was
800 ms. Exposure time for red ﬂuorescent images of DsRed was 2 s due to weaker ﬂuorescence. The bar represents 20 lm.
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Fig. 2. Flow cytometry results showing that inhibition of green ﬂuorescent intensities of GFP-Bcl-xL by DsRed or DsRed-Express2 in HeLa cells. A. GFP-Bcl-xL plasmids were
transiently co-transfected with plasmids as indicated in HeLa cells. Green ﬂuorescent cells were counted by ﬂow cytometry at 48 h. The data were analyzed by the software
summit 4.0. (B) Normalized ﬂuorescence intensity of cells transfected with plasmids as indicated in HeLa cells. The strongest green ﬂuorescence intensity obtained for cells
expressing GFP-Bcl-xL alone was deﬁned as 100 units.
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xL and exogenous GFP-Bcl-xL protein levels, which explains the
lowered green ﬂuorescence intensity in HeLa cells.
3.2. DsRed represses the expression of Bcl-xL by translational
regulation
To decrease the GFP-Bcl-xL protein level, DsRed could act to
accelerate the protein degradation, or down-regulate either the
protein or the mRNA production. To distinguish these possibilities,
we constructed a plasmid encoding GFP(⁄)-Bcl-xL, in which a stop
codon was inserted between GFP and Bcl-xL coding sequences so
that only GFP protein could be produced even though the mRNA
contained the coding sequence of Bcl-xL. Interestingly, when plas-
mids encoding DsRed and GFP(⁄)-Bcl-xL were co-transfected into
HeLa cells, the green ﬂuorescence intensity was still weaker than
that of cells expressing DsRed and GFP (Fig. 1b4 and b1). Similarresults were also observed in cells expressing DsRed-Express2
and GFP(⁄)-Bcl-xL (Fig. 1f4). Considering that DsRed or DsRed-Ex-
press2 does not affect GFP protein production when there is no
Bcl-xL coding sequence (Fig. 1b1 and g1), these results suggest that
DsRed or DsRed-Express2 represses expression of Bcl-xL by tran-
scription or translational regulation.
We next investigated whether DsRed inhibited the transcription
of Bcl-xL in HeLa cells. We extracted the total RNA of HeLa cells co-
transfected with plasmids encoding GFP-Bcl-xL and DsRed or
empty vector, and used RT-PCR to amplify a fragment of GFP-
Bcl-xL cDNA. As shown in Fig. 4A, DsRed did not inhibit the tran-
scription of GFP-Bcl-xL mRNA, as the band intensities of RT-PCR
products are comparable. We then transfected plasmids encoding
DsRed or empty vector into HeLa cells, and examined whether
the transcription of endogenous Bcl-xL was affected by the over-
expression of DsRed. Same as exogenous results, DsRed also did
not inhibit the transcription of endogenous Bcl-xL (Fig. 4B). These
Fig. 3. Inhibition of Bcl-xL expression by DsRed or DsRed-Express2 in HeLa cells.
Down-regulation of both exogenous and endogenous expression of Bcl-xL by the
overexpression of DsRed and DsRed-Express2. HeLa cells co-transfected with
plasmids expressing GFP-Bcl-xL together with DsRed, DsRed-Express2 or Turbo RFP.
The expression of both exogenous (upper panel) and endogenous of Bcl-xL (lower
panel) was determined by western blotting.
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by translational regulation.
3.3. Over expression of Bcl-xL reduces the cytotoxicity of DsRed and
DsRed-Express2 in HeLa cells
We next evaluated the effect of Bcl-xL on DsRed-mediated cyto-
toxicity in HeLa cells. When cells were transfected with plasmids
encoding DsRed alone, 51.7% of red ﬂuorescent cells became shriv-
eled and round after 48 h. However, when cells were transfected
with plasmids encoding both DsRed and Bcl-xL, only 9% red ﬂuo-
rescent cells appeared to be shriveled and round after 48 h
(Fig. 5A). As a control, only 6% of green ﬂuorescent cells appeared
to be shriveled. Since Bcl-xL is an important negative-regulator of
apoptosis, we analyzed the effect of Bcl-xL on DsRed-elicited apop-
tosis by using Hochest 33342. The percentage of apoptotic cells
was about 11.25% in cells which were transfected with plasmids
encoding DsRed alone, while it was decreased to 3.4% in cells trans-
fected with plasmids encoding both DsRed and GFP-Bcl-xL (Fig. 5B
and C).
DsRed-Express2 was reported to be the best variant derivative
of DsRed. The ﬂuorescence maturation, expression, photostability
and photoxicity were much more improved compared with DsRed
[10]. When cells were transfected with plasmids encoding DsRed-
Express2 alone, there are also 23.5% of red ﬂuorescent cells became
shriveled and round after 48 h. However, when cells were transfec-
ted with plasmids encoding both DsRed-Express2 and Bcl-xL, only
3.8% red ﬂuorescent cells appeared to be shriveled and round afterFig. 4. DsRed did not inhibit the transcription of Bcl-xL in Hela cells. (A) RT-PCR assay of t
with plasmids expressing GFP-Bcl-xL and DsRed or plasmids expressing GFP-Bcl-xL alon
HeLa cells transfected with plasmids expressing DsRed. Both exogenous and endogenous
used as an internal control. M: DNA ladder.48 h (Fig. 5A). Apoptosis analysis by Hochest 33342 showed the
percentage of apoptotic cells was about 6.3% in cells which were
transfected with plasmids encoding DsRed-Express2 alone, while
it was decreased to 3.5% in cells transfected with plasmids encod-
ing both DsRed-Express2 and Bcl-xL (Fig. 5B and C).
To further evaluate Bcl-xL on the inhibition of DsRed or
DsRed-Express2-elicited cytotoxicity, percentage of ﬂuorescent
cells was counted by ﬂow cytometry at the time from 12 to
84 h after transfections (Supplementary Fig. 1). Over-expression
of Bcl-xL did not increase percentage of green ﬂuorescent cells
(Supplementary Fig. 1A). However, over-expression of Bcl-xL
obviously increased percentage of red ﬂuorescent cells expressing
DsRed (Supplementary Fig. 1B). Besides, numbers of red ﬂuores-
cent cells expressing DsRed-Express2 was also increased
(Supplementary Fig. 1C).
Our results indicate that the cytotoxicity of DsRed and DsRed-
Express2 is correlated with the down regulation of Bcl-xL, while
overexpression of Bcl-xL can decrease the cytotoxicity of DsRed
and DsRed-Express2 in HeLa cells.
3.4. Turbo RFP does not inhibit the expression of Bcl-xL protein
Turbo RFP and its mutant TagRFP are also widely applied in red
ﬂuorescent imaging. Turbo RFP is a dimeric RFPfrom Entacmaea
quadricolor, and it is much brighter than DsRed [18]. We also inves-
tigated whether Turbo RFP inhibited the ﬂuorescence of GFP-Bcl-xL
or GFP-Bcl-2. The ﬂuorescence image results showed that Turbo
RFP did not inhibit the green ﬂuorescence intensity of GFP-Bcl-2,
GFP-Bcl-xL and GFP-(⁄)-Bcl-xL in HeLa cells (Figs. 1d2–d4, and
2). Further, western blot results conﬁrmed that Turbo RFP did
not inhibit the expression of Bcl-xL protein in HeLa cells (Fig. 3).
Accordingly, Turbo RFP did not show obvious toxicity in HeLa cells
in three days (Fig. 5), and Bcl-xL had no effect on proliferation of
cells expressing Turbo RFP (Supplementary Fig. 1D).
We also compared the average ﬂuorescence intensity for cells
transfected with DsRed, DsRed-Express2, Turbo RFP or GFP at 48
and 60 h, and the results showed that cells transfected with Turbo
RFP or GFP shownmuch higher average ﬂuorescence intensity than
those of DsRed and DsRed-Express2 (Supplementary Fig. 2). The
protein expression level can be estimated from dividing the aver-
age ﬂuorescence intensity by the relative brightness of each ﬂuo-
rescent protein. As shown in Supplementary Fig. 3 [19–21], the
expression levels of DsRed-Express2, Turbo RFP and GFP are com-
parable, and are about 10 times higher than that of DsRed. Consid-
ering that DsRed has much longer maturation time, even if only
10% of the expressed DsRed is matured, its expression level is just
comparable to the other ﬂuorescent proteins. Therefore, the differ-
ence in cytotoxicity is not related to the expression level of ﬂuores-
cent protein.he transcription of exogenous Bcl-xL mRNA extracted from HeLa cells co-transfected
e. (B) RT-PCR assay of the transcription of endogenous Bcl-xL mRNA extracted from
Bcl-xL mRNA levels were not affected by the overexpression of DsRed. GAPDH was
Fig. 5. Over-expression of Bcl-xL inhibits DsRed-mediated cytotoxicity. (A) The percentage of shriveled cells for HeLa cells co-transfected with plasmids expressing both GFP-
Bcl-xL and DsRed/DsRed-Express2 or expressing DsRed/DsRed-Express2 alone, and cells expressing GFP alone were used as control. Over-expression of Bcl-xL inhibits DsRed
and DsRed-Express2 elicited shriveled cells. (B) Representative ﬂuorescence images of HeLa cells co-transfected with plasmids expressing both GFP-Bcl-xL and DsRed/DsRed-
Express2 or DsRed/DsRed-Express2 alone, and cells expressing GFP alone were used as control. Hoechest 33342 was used for staining apoptotic cells. The bar represents 20 m.
(C) The percentage of apoptotic cells for HeLa cells co-transfected with plasmids expressing both GFP-Bcl-xL and DsRed/DsRed-Express2 or expressing DsRed/DsRed-Express2
alone, and cells expressing GFP alone were used as control. ⁄P < 0.01.
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In summary, we have demonstrated that DsRed and DsRed-
Express2 can inhibit the expression of anti-apoptotic protein
Bcl-xL, which results in cytotoxicity in Hela cells. Meanwhile, the
over-expression of Bcl-xL inhibits DsRed-mediated cytotoxicity.
Our results reveal a possible mechanism of DsRed cytotoxicity,
further investigating the detail mechanism for DsRed and DsRed-
Express2 on inhibition of Bcl-xL translation may help to alleviate
the cytotoxic problem of DsRed and its variants.
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